Cannaisseur Group Inc. is a U.S.-based micro-cap company formed in December 2020 that acquired a controlling 51% interest in Atlanta CBD Inc., which operates under the Inno Medicinals trade name. The business started in hemp cultivation, extraction, manufacturing, distribution, and CBD retail, and has since shifted toward health and wellness products centered on CBD-related offerings. Today, the company says its only operating assets and activities are tied to Atlanta CBD’s retail store in Atlanta, Georgia and its e-commerce channel. Management also describes the company as being in an early-stage expansion phase, with operations dependent on external financing and continued development of the product line.
−180 939,9 %
−510,7 %
−181 348,3 %
−98,7 %
0.01
0.00
| % | |
|---|---|
| CBD and hemp retail products | 80% Consumer-facing CBD-related and hemp-derived products sold through retail and online channels. |
| Health and wellness products | 20% Broader wellness offerings the company says it is transitioning toward beyond core CBD items. |
The company sells directly to consumers who buy CBD-related products for wellness, relaxation, and general self-care...
Customers visiting the Atlanta store to buy CBD-related products at point of sale for immediate use and convenience.
Online buyers who purchase products through the website and value convenience, product availability, and direct shipping.
Consumers attracted to the company's broader wellness positioning and CBD-related product assortment.
Customers who return for familiar hemp-derived products and consistent product quality.
The company’s operating footprint is highly concentrated in Atlanta, Georgia, where Atlanta CBD runs its retail...
Management’s near-term priority is to keep the business funded while supporting day-to-day operations at Atlanta CBD...
The company has limited operating scale and a going-concern warning, so funding is necessary to maintain operations and execute its plan.
The company currently relies on a single operating subsidiary, so maintaining sales and execution there is essential.
A wider product set could reduce dependence on a narrow CBD-only proposition and improve market relevance.
The company faces substantial going-concern and liquidity risk because it has limited operating history, negative...
The company disclosed substantial doubt about its ability to continue as a going concern and says it needs additional capital to fund operations.
Current operations consist only of the 51% interest in Atlanta CBD, making the business highly dependent on one subsidiary and one retail footprint.
The company sells hemp-derived and CBD-related products, which are subject to evolving federal and state rules.
Management cites an intense competitive environment and potential declines in consumer spending on its offerings.
Inflation, higher interest rates, and recession risk can reduce discretionary spending and make financing more difficult.
CBDY · Medicinal Chemicals & Botanical Products
YCBD · Perfumes, Cosmetics & Other Toilet Preparations
CPMD · Pharmaceutical Preparations
Agricultural Production-Crops
Cannabist Co Holdings Inc., formerly Columbia Care, is a U.S.
CGC · Medicinal Chemicals & Botanical Products
Canopy Growth Corp is a cannabis and hemp company built around medical cannabis brands, vaporizers, and a portfolio of U.S.
CVSI · Pharmaceutical Preparations
: 28/04/2026